Advertisement

European Radiology

, Volume 23, Issue 11, pp 3185–3190 | Cite as

Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard

  • L. Schimmöller
  • M. QuentinEmail author
  • C. Arsov
  • R. S. Lanzman
  • A. Hiester
  • R. Rabenalt
  • G. Antoch
  • P. Albers
  • D. Blondin
Urogenital

Abstract

Objectives

The recent European Society of Urogenital Radiology (ESUR) guidelines for evaluation and reporting of prostate multiparametric magnetic resonance imaging (mp-MRI) include the Prostate Imaging Reporting and Data System (PI-RADS). The aim of this study was to investigate the inter-reader agreement of this scoring system.

Methods

One hundred and sixty-four lesions in 67 consecutive patients with elevated prostate-specific antigen and previously negative trans-rectal ultrasound (TRUS)-guided biopsy were scored retrospectively by three blinded readers using PI-RADS. Mp-MRI was performed at 3 T using T2-weighted, diffusion-weighted and dynamic contrast-enhanced imagings (T2WI, DWI, DCE-MRI). Histology of all lesions was obtained by in-bore MRI-guided biopsy. Cohen’s kappa statistics were calculated for all readers.

Results

Inter-reader agreement for all lesions was good to moderate (T2WI, κ = 0.55; DWI, κ = 0.64; DCE-MRI, κ = 0.65). For tumour lesions it was good (T2WI, κ = 0.66; DWI, κ = 0.80; DCE-MRI, κ = 0.63) and for benign lesions moderate to good (T2WI, κ = 0.46; DWI, κ = 0.52; DCE-MRI, κ = 0.67). Using an overall PI-RADS score with a threshold of ≥10, we achieved a sensitivity of 85.7 %, and negative predictive value of 90.1 % for biopsied lesions.

Conclusion

PI-RADS score shows good to moderate inter-reader agreement and enables standardised evaluation of prostate mp-MRI, with high sensitivity and negative predictive value.

Key Points

The European Society of Urogenital Radiology recently published guidelines for prostate MRI.

We have evaluated inter-reader agreement of ESUR scoring for multiparametric prostate MRI.

PI-RADS shows good to moderate inter-reader agreement and is clinically applicable.

PI-RADS achieves in our series high sensitivity and negative predictive value for biopsied lesions.

PI-RADS can be used as standardised scoring system in prostate cancer detection.

Keywords

Prostate cancer Prostate MRI PI-RADS ESUR Scoring MRI-guided biopsy 

Abbreviations

ESUR

European Society of Urogenital Radiology

PI-RADS

Prostate Imaging Reporting and Data System

mp-MRI

Multiparametric magnetic resonance imaging

DCE

Dynamic contrast-enhanced imaging

MRSI

Spectroscopic imaging

DWI

Diffusion-weighted imaging

PSA

Prostate-specific antigen

TRUS

Trans-rectal ultrasound

References

  1. 1.
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) GLOBOCAN 2008 v2.0, cancer incidence and mortality worldwide: IARC CancerBase No. 10. International Agency for Research on Cancer, Lyon, France. Available via http://globocan.iarc.fr. Accessed 15. January 2013
  2. 2.
    Mistry K, Cable G (2003) Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma. J Am Board Fam Pract 16:95–101PubMedCrossRefGoogle Scholar
  3. 3.
    Heidenreich A, Aus G, Bolla M et al (2008) EAU guidelines on prostate cancer. Eur Urol 53:68–80PubMedCrossRefGoogle Scholar
  4. 4.
    Dickinson L, Ahmed HU, Allen C et al (2011) Magnetic resonance imaging for the detection, localization and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 59:477–494PubMedCrossRefGoogle Scholar
  5. 5.
    Umbehr M, Bachmann LM, Held U et al (2009) Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. Eur Urol 55:575–590PubMedCrossRefGoogle Scholar
  6. 6.
    Mazaheri Y, Shukla-Dave A, Muellner A et al (2008) MR imaging of the prostate in clinical practice. MAGMA 21:379–392PubMedCrossRefGoogle Scholar
  7. 7.
    Hoeks CM, Barentsz JO, Hambrock T et al (2011) Prostate cancer: multi-parametric MR imaging for detection, localization, and staging. Radiology 261:46–66PubMedCrossRefGoogle Scholar
  8. 8.
    Heidenreich A, Bellmunt J, Bolla M et al (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59:61–71PubMedCrossRefGoogle Scholar
  9. 9.
    Portalez D, Rollin G, Leandri P et al (2010) Prospective comparison of T2w- MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies. Eur Radiol 20:2781–2790PubMedCrossRefGoogle Scholar
  10. 10.
    Hricak H, Choyke PL, Eberhardt SC et al (2007) Imaging prostate cancer: a multidisciplinary perspective. Radiology 243:28–53PubMedCrossRefGoogle Scholar
  11. 11.
    Barentsz JO, Richenberg J, Clements R et al (2012) ESUR prostate MR guidelines 2012. Eur Radiol 22:746–757PubMedCrossRefGoogle Scholar
  12. 12.
    American College of Radiology (2003) Breast Imaging Reporting and Data System (BI-RADS), Breast Imaging Atlas, 4th edn. American College of Radiology (ACR), RestonGoogle Scholar
  13. 13.
    Molleran V, Mahoney MC (2010) The BI-RADS breast magnetic resonance imaging lexicon. Magn Reson Imaging Clin N Am 18:171–185PubMedCrossRefGoogle Scholar
  14. 14.
    Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRefGoogle Scholar
  15. 15.
    “Interdisziplinären Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms”. Available via http://www.awmf.org/leitlinien/detail/ll/043-022OL.html. Accessed 01. April 2013
  16. 16.
    Hara N, Okuizumi M, Koike H, Kawaguchi M, Bilim V (2005) Dynamic contrast-enhanced magnetic resonance imaging (DCEMRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate 62:140–147PubMedCrossRefGoogle Scholar
  17. 17.
    Delongchamps NB, Rouanne M, Flam T et al (2011) Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging. BJU Int 7:1411–1418CrossRefGoogle Scholar
  18. 18.
    Anastasiadis AG, Lichy MP, Nagele U et al (2006) MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. Eur Urol 50:738–748PubMedCrossRefGoogle Scholar
  19. 19.
    Roethke M, Anastasiadis AG, Lichy M et al (2012) MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy. World J Urol 30:213–218PubMedCrossRefGoogle Scholar
  20. 20.
    Franiel T, Stephan C, Erbersdobler A, Dietz E, Maxeiner A et al (2011) Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding—multiparametric MR imaging for detection and biopsy planning. Radiology 259:162–172PubMedCrossRefGoogle Scholar
  21. 21.
    Hambrock T, Somford DM, Hoeks C et al (2010) Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. J Urol 183:520–527PubMedCrossRefGoogle Scholar
  22. 22.
    Kobus T, Vos PC, Hambrock T, De Rooij M, Hulsbergen-van de Kaa CA, Barentsz JO, Heerschap A, Scheenen TWJ (2012) Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T. Radiology 265:457–467PubMedCrossRefGoogle Scholar
  23. 23.
    Futterer JJ, Scheenen TW, Heijmink SW et al (2007) Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate. Invest Radiol 42:116–122PubMedCrossRefGoogle Scholar
  24. 24.
    Arsov C, Quentin M, Rabenalt R, Antoch G, Albers P, Blondin D (2012) Repeat transrectal ultrasound biopsies with additional targeted cores according to results of functional prostate MRI detects high-risk prostate cancer in patients with previous negative biopsy and increased PSA—a pilot study. Anticancer Res 32:1087–1092PubMedGoogle Scholar
  25. 25.
    Arsov C, Blondin D, Rabenalt R, Antoch G, Albers P, Quentin M (2012) Standardised scoring of a multi-parametric 3-T MRI for a targeted MRI-guided prostate biopsy. Urologe 51:848–856PubMedCrossRefGoogle Scholar
  26. 26.
    Quentin M, Arsov C, Röhlen S et al (2012) Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system. Röfo 184:925–929PubMedGoogle Scholar
  27. 27.
    Kirkham AP, Emberton M, Allen C (2006) How good is MRI at detecting and characterising cancer within the prostate? Eur Urol 50:1163–1174PubMedCrossRefGoogle Scholar
  28. 28.
    Choi YJ, Kim JK, Kim N et al (2007) Functional MR imaging of prostate cancer. Radiographics 27:63–75PubMedCrossRefGoogle Scholar
  29. 29.
    Bratan F, Niaf E, Melodelima C, Chesnais AL, Souchon R, Mège-Lechevallier F, Colombel M, Rouvière O (2013) Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Eur Radiol. doi: 10.1007/s00330-013-2795-0 PubMedGoogle Scholar
  30. 30.
    Chesnais AL, Niaf E, Bratan F, Mège-Lechevallier F, Roche S, Rabilloud M, Colombel M, Rouvière O (2013) Differentiation of transitional zone prostate cancer from benign hyperplasia nodules: evaluation of discriminant criteria at multiparametric MRI. Clin Radiol 68:e323–e330PubMedCrossRefGoogle Scholar

Copyright information

© European Society of Radiology 2013

Authors and Affiliations

  • L. Schimmöller
    • 1
  • M. Quentin
    • 1
    Email author
  • C. Arsov
    • 2
  • R. S. Lanzman
    • 1
  • A. Hiester
    • 2
  • R. Rabenalt
    • 2
  • G. Antoch
    • 1
  • P. Albers
    • 2
  • D. Blondin
    • 1
  1. 1.Medical Faculty, Department of Diagnostic and Interventional Radiology, University DusseldorfDusseldorfGermany
  2. 2.Medical Faculty, Department of UrologyUniversity DusseldorfDusseldorfGermany

Personalised recommendations